Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery |
| |
Authors: | SA Gould EE Moore FA Moore JB Haenel JM Burch H Sehgal L Sehgal R DeWoskin GS Moss |
| |
Affiliation: | Department of Surgery, Michael Reese Hospital and University of Illinois, Chicago, USA. |
| |
Abstract: | We have previously documented the safety of 1 unit (50 gram) of human polymerized hemoglobin (Poly SFH-P) in healthy volunteers. This report describes the first patient trial to assess the therapeutic benefit of Poly SFH-P in acute blood loss. Thirty-nine patients received 1 (n = 14), 2 (n = 2), 3 (n = 15), or 6 (n = 8) units of Poly SFH-P instead of red cells as part of their blood replacement after trauma and urgent surgery. There were no safety issues related to the infusion of Poly SFH-P. The plasma hemoglobin concentration (Hb]) after the infusion of 6 units (300 gram) of Poly SFH-P was 4.8 +/- 0.8 g/dL (mean +/- SD). Although the red cell Hb] fell to 2.9 +/- 1.2 g/dL, the total Hb] was maintained at 7.5 +/- 1.2 g/dL. Poly SFH-P maintained total Hb], despite the marked fall in red cell Hb] due to blood loss. The utilization of O2 (extraction ratio) was 27 +/- 16% from the red cells and 37 +/- 13% from the Poly SFH-P. Twenty-three patients (59%) avoided allogeneic transfusions during the first 24 hours after blood loss. Poly SFH-P effectively loads and unloads O2 and maintains total hemoglobin in lieu of red cells after acute blood loss, thereby reducing allogeneic transfusions. Poly SFH-P seems to be a clinically useful blood substitute. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|